Medfinder
Back to blog

Updated: March 26, 2026

What Is Apomorphine? Uses, Dosage, and What You Need to Know in 2026

Author

Peter Daggett

Peter Daggett

Large medication capsule with information icon and educational elements

Apomorphine (Apokyn, Onapgo) is a dopamine agonist used to treat Parkinson's disease off episodes. Here's a complete plain-language guide to what it is and how it works.

Apomorphine is a medication used to treat advanced Parkinson's disease. Despite having "morphine" in its name, it is not an opioid and is not related to morphine—it does not relieve pain, and it does not cause opioid-type dependence. Instead, apomorphine works directly on the brain's dopamine system to temporarily restore movement control when Parkinson's symptoms break through other medications. This guide explains everything you need to know about apomorphine in plain language.

What Is Apomorphine Used For?

Apomorphine is FDA-approved for the acute, intermittent treatment of hypomobility "off" episodes in people with advanced Parkinson's disease. "Off" episodes are times when Parkinson's symptoms—such as rigidity, tremor, slow movement, and difficulty walking—return because the regular medication (usually levodopa) has worn off or become less effective.

Apomorphine acts as a "rescue" medication—it is used when an off episode occurs, not as a regular daily maintenance drug. It works rapidly (within 10–20 minutes) to bring patients back to their "on" state, restoring better mobility for 45–90 minutes per dose.

What Are the Brand Names for Apomorphine?

In the United States, apomorphine is available under two current brand names:

Apokyn: A subcutaneous (under-the-skin) injection pen, used as-needed when off episodes occur. First FDA approved in 2004. A generic version is now available from TruPharma.

Onapgo: A wearable continuous subcutaneous infusion device approved by the FDA in February 2025. Onapgo delivers apomorphine continuously over 16 waking hours for more consistent motor control throughout the day.

Kynmobi (apomorphine sublingual film) has been discontinued in the US market.

How Is Apomorphine Given?

Apomorphine cannot be taken by mouth. When swallowed, the liver destroys it before it can reach the brain—a process called first-pass metabolism. It must be given under the skin (subcutaneously).

For Apokyn injection: The injection can be given in the abdomen (at least 2 inches from the belly button), upper arm, or upper thigh. Rotate injection sites with every dose to prevent skin nodules. The solution should be clear and colorless—do not use it if it has turned green or contains particles.

For Onapgo: A small cannula (thin tube) is placed under the skin and connected to the wearable pump device. The device delivers a continuous, low dose throughout the waking day and can also deliver extra doses when needed.

What Is the Dose of Apomorphine?

Dosing for Apokyn (as-needed injection):

Starting dose: 0.2 mL (2 mg), given under medical supervision on the first occasion

Titration: Adjusted up or down based on response and tolerability

Maximum single dose: 0.6 mL (6 mg)

Doses must be at least 2 hours apart; maximum ~5 times per day; maximum ~20 mg/day

Dosing for Onapgo (continuous infusion):

Starting continuous dose: 1 mg/hr

Titration: Increased in 0.5–1 mg/hr increments; mean clinical dose ~4 mg/hr

Maximum total daily dose: 98 mg, administered over ~16 waking hours

Important Things to Know Before Starting Apomorphine

Anti-nausea medicine required: Trimethobenzamide must be started 3 days before your first dose to prevent severe nausea and vomiting.

First dose in clinic: Your first dose must be given under medical supervision at your doctor's office or clinic. You cannot start apomorphine at home.

Not a controlled substance: Despite having 'morphine' in its name, apomorphine is NOT a DEA-scheduled controlled substance. It does not bind to opioid receptors.

Specialty pharmacy only: Apomorphine can only be filled at specialty pharmacies, not standard retail pharmacies.

Ondansetron (Zofran) is contraindicated: Taking ondansetron or other 5-HT3 antagonists with apomorphine can cause life-threatening low blood pressure and loss of consciousness.

To understand how apomorphine works in the brain, read our companion guide: How does apomorphine work? Mechanism of action explained in plain English.

If you have trouble finding apomorphine in stock, medfinder calls pharmacies near you to find which ones have it available.

Frequently Asked Questions

No. Despite the similar name, apomorphine is not morphine and is not an opioid. It does not bind to opioid receptors and does not relieve pain. Apomorphine is a dopamine agonist that acts on dopamine receptors in the brain. The 'apo-' prefix indicates it is derived from (made from) morphine through a chemical process, but it has a completely different structure and mechanism of action.

Apomorphine is appropriate for adults with advanced Parkinson's disease who are experiencing significant 'off' episodes despite optimized oral therapy with carbidopa/levodopa and/or other Parkinson's medications. A movement disorder specialist or neurologist will evaluate whether apomorphine is appropriate for your specific situation.

Levodopa is converted into dopamine in the brain and acts as a replacement for the dopamine that Parkinson's disease destroys. Apomorphine directly mimics dopamine by binding to dopamine receptors without needing to be converted. This bypasses the conversion step and reaches the brain faster—which is why it works within 10–20 minutes, much faster than oral levodopa.

No. Apomorphine does not cure or slow the progression of Parkinson's disease. It manages symptoms by temporarily replacing the lost dopamine signal in the brain. Parkinson's disease is progressive, and while apomorphine can significantly improve quality of life during off episodes, it does not address the underlying neurodegeneration.

Apomorphine has been used in Europe for Parkinson's disease since the 1990s. In the United States, Apokyn (subcutaneous injection) was approved by the FDA in 2004. The new Onapgo wearable continuous infusion device received FDA approval in February 2025, though the continuous infusion approach has a 30-year track record in Europe.

Medfinder Editorial Standards

Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.

Read our editorial standards

Patients searching for Apomorphine also looked for:

33,257 have already found their meds with Medfinder.

Start your search today.

33K+
5-star ratingTrusted by 33,257 Happy Patients
      What med are you looking for?
⊙  Find Your Meds
99% success rate
Fast turnaround time
Never call another pharmacy

Need this medication?